Related Experiment Video
Updated: Sep 29, 2026

Histological Quantification of Chronic Myocardial Infarct in Rats
Published on: December 11, 2016
Clinical and pathobiologic considerations in the evaluation of markers of myocardial ischemia
1Jewish Hospital Heart and Lung Institute, Louisville KY 40202, USA. jadams03@sprynet.com
Insights
Developing blood tests for myocardial ischemia requires careful consideration of diverse causes. A single "marker for ischemia" is unlikely; situation-specific proteins and assays are more probable for detecting heart issues.
Area of Science:
- Cardiology
- Biomarker Discovery
- Ischemic Heart Disease
Background:
- There is a critical need for blood-based assays to detect myocardial ischemia and identify at-risk patients.
- Unstable angina has diverse etiologies and complex cellular interactions, complicating the search for a universal ischemia marker.
Purpose of the Study:
- To explore the challenges and considerations in developing blood-based analytic techniques for detecting myocardial ischemia.
- To discuss the limitations of a singular "marker for ischemia" and the potential need for situation-specific biomarkers.
Main Methods:
- Review of existing literature on myocardial ischemia and biomarker discovery.
- Analysis of the complexities in identifying proteins indicative of ischemia across various pathological conditions.
- Discussion on the selection of appropriate gold standards for assay validation.
Main Results:
- A single protein marker for all types of ischemia is improbable due to diverse etiologies.
- A spectrum of situationally specific proteins and corresponding analytic assays will likely be necessary.
- The selection of a gold standard is a crucial and challenging decision in assay development.
Conclusions:
- Caution is advised when using the term "marker for ischemia" due to the complexity of the condition.
- Future research should focus on identifying situation-specific biomarkers and validating assays rigorously.
- Clinical trial data is essential to generalize the usefulness of any ischemia detection assay.
Abstract:
There is a need for blood-based analytic techniques that allow for the detection of patients either with reversible myocardial ischemia or who are at risk for myocardial ischemia. However, given the diverse etiologies of unstable angina and the complex interactions among various cell types, the term "marker for ischemia" should be used with caution (if at all). Unless we find a protein that is released across the diverse pathologic triggers associated with the various stages of progression of atherosclerosis and cellular ischemia, we will be forced to consider a spectrum of proteins (and analytic assays) that are situationally specific. The choice of an appropriate gold standard as we investigate the clinical application of these assays will be one of the most difficult and most important decisions in these studies. It will be critical that conclusions of usefulness in one setting of ischemic heart disease not be generalized in the absence of clinical trials supporting that contention.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Myocarditis II: Clinical Features and Diagnostic Tests
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Angina III: Clinical Manifestations and Assessment
